Addiction

World-Leading Schizophrenia Expert Dr. Jeffrey A. Lieberman Unravels the Mysteries of Schizophrenia on The People’s Pharmacy

NEW YORK, NY / ACCESSWIRE / February 21, 2024 / Millions of Americans live with schizophrenia, a complex and long…

2 years ago

Netsmart Maintains Top EHR PM Satisfaction Ratings Among Behavioral Health Providers in Black Book’s 2024 Tech User Survey

TAMPA, FL / ACCESSWIRE / February 21, 2024 / In Black Book Research's annual client experience performance ratings for enterprise…

2 years ago

SkywardRx Forges Alliance With Victoria’s Voice Foundation to Propel Naloxone Awareness Across Extensive Distribution Channels

ORLANDO, FL / ACCESSWIRE / February 21, 2024 / SkywardRx, an innovative digital healthcare consulting company, today announced it has…

2 years ago

BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

BURLINGTON, Mass. and JERUSALEM, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…

2 years ago

PillSafe’s Revolutionary Technology Protects Patients and Physicians From Overuse and Abuse of Opioids

As doctors balance the risks and benefits of pain management, PillSafe technology ensures the managed delivery and distribution of controlled…

2 years ago

Southwest Behavioral Health Center Provides Notice Following Data Security Incident

ST. GEORGE, Utah, Feb. 15, 2024 /PRNewswire/ -- Southwest Behavioral Health Center ("SBHC") is a public provider of comprehensive, integrated…

2 years ago

Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20

CHARLOTTESVILLE, VA / ACCESSWIRE / February 15, 2024 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)(NASDAQ:ADILW) ("Adial" or the "Company"), a clinical-stage biopharmaceutical…

2 years ago

Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Risk of Addiction

Non-opioid drug candidate from Tonix lowered pain and also improved sleep and fatigueLatest Phase 3 trial achieved primary endpoint (p=0.00005)Potential…

2 years ago

RespireRx Pharmaceuticals Inc. Reports Preclinical Pain Relief for their Non-Opioid Lead GABAkine

Glen Rock, N.J., Feb. 13, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the “Company”),…

2 years ago